Programme

HKT
Lecture Theatre 1A
Lecture Theatre 1B
Room 209
  • 09:00
  • 09:10
  • 09:20
  • 09:30
  • 09:40
  • 09:50
  • 10:00
  • 10:10
  • 10:20
  • 10:30
  • 10:40
  • 10:50
  • 11:00
  • 11:10
  • 11:20
  • 11:30
  • 11:40
  • 11:50
  • 12:00
  • 12:10
  • 12:20
  • 12:30
  • 12:40
  • 12:50
  • 13:00
  • 13:10
  • 13:20
  • 13:30
  • 13:40
  • 13:50
  • 14:00
  • 14:10
  • 14:20
  • 14:30
  • 14:40
  • 14:50
  • 15:00
  • 15:10
  • 15:20
  • 15:30
  • 15:40
  • 15:50
  • 16:00
  • 16:10
  • 16:20
  • 16:30
  • 16:40
  • 16:50
  • 17:00
  • 17:10
  • 17:20
  • 17:30
  • 17:40
  • 17:50
  • 18:00
  • 18:10
  • 18:20
Lecture Theatre 1A
Lecture Theatre 1B
Room 209
Endoscopy Live Demonstration (1)
Lecture Theatre 1A
09:00-10:15
09:00
Endoscopy Live Demonstration (1)
Hepatology (1) – HBV
Lecture Theatre 1B
09:00-10:15
09:00
HBV cure with direct-acting antivirals - are we getting close?
09:25
Watch out HBV in the era of COVID-19
09:50
Eliminating mother-to-child transmission of HBV
GUT-IDDF Young Investigator Award: Oral Presentation I
Room 209
09:00-10:15
09:00
GUT-IDDF Young Investigator Award: Oral Presentation I
Endoscopy Live Demonstration (2)
Lecture Theatre 1A
10:45-12:00
10:45
Endoscopy Live Demonstration (2)
Hepatology (2) - NAFLD/MAFLD
Lecture Theatre 1B
10:45-12:00
10:45
Existing metabolic drugs for the treatment of NASH
11:10
FXR agonists and FGF analogues
11:35
MRI assessment of treatment response and prognosis
GUT-IDDF Young Investigator Award: Oral Presentation II
Room 209
10:45-12:00
10:45
GUT-IDDF Young Investigator Award: Oral Presentation II
Lunch Symposium (A)
Lecture Theatre 1A
13:00-14:00
13:00
Lunch Symposium (A)
Lunch Symposium (B)
Lecture Theatre 1B
13:00-14:00
13:00
Lunch Symposium (B)
Opening Ceremony, Joseph Sung Distinguished Lecture & Dr S H Ho Memorial Lecture
Lecture Theatre 1A
14:00-15:20
14:00
Opening Ceremony
14:20
Joseph Sung Distinguished Lecture
14:50
Dr S H Ho Memorial Lecture: Hepatitis B - then and now
Advances in IBD
Lecture Theatre 1A
15:50-17:05
15:50
IBD home monitoring & FC home test
16:15
Patients’ perspectives and expectations in the treatment of inflammatory bowel disease
16:40
Biosimilar
State Key Lab Meeting (1) - Molecular mechanisms of GI cancer
Lecture Theatre 1B
15:50-17:05
15:50
Genetic and epigenetic alterations in gastric cancer
16:15
Mettl3 as a therapeutic target in colorectal cancer
16:40
Dual function of MEN1 in modulating colon cancer tumor-microenvironment interactions
JGH-IDDF Case / Video Champion: Oral Presentation
Room 209
15:50-18:20
15:50
JGH-IDDF Case / Video Champion: Oral Presentation
Challenging GI bleeders
Lecture Theatre 1A
17:05-18:20
17:05
Endoscopy in patients receiving complex anti-thrombotic therapy
17:30
Management of difficult bleeders
17:55
Topic TBA
State Key Lab Meeting (2) - Microbiome/metabolites, gut-liver axis and liver diseases
Lecture Theatre 1B
17:05-18:20
17:05
Enterically derived HDL restrains liver injury through the portal vein
17:30
Intestine gene regulates NAFLD through gut-liver axis
17:55
Fecal mycobiome in NAFLD
** Programme is subject to change without prior notice